BASEL, Switzerland â April 10, 2026 – The Pharma Partnering EU Summit 2026 will take place in Basel, Switzerland, on May 20â21, 2026, bringing together global leaders in business development and licensing from pharmaceutical and biotech organizations.
The summit provides a dynamic, partnership-focused environment for executives, innovators, and investors to explore licensing deals, co-development opportunities, joint ventures, and strategic alliances. With Baselâs reputation as a European pharmaceutical hub, PPS EU 2026 offers attendees a unique opportunity to connect with industry peers, share insights, and drive tangible collaborations.
âPPS EU is where global BD&L leaders meet to turn ideas into actionable partnerships,â said Olivia Grey, Conference Manager. âFrom structured one-on-one meetings to curated networking sessions, our goal is to enable companies to discover and execute deals that advance innovation and growth across the pharma and biotech sectors.â
Key features of PPS EU 2026 include:
- One-to-One Partnering Meetings: Pre-arranged sessions with qualified senior executives to explore collaborations, licensing, and investment opportunities.
- Company Presentations: Focused pitches to showcase assets, technologies, and opportunities to the right audience.
- Panel Discussions: Expert insights on industry trends, emerging therapies, and global BD&L strategies.
- Networking Lounges: Dedicated time to build long-term relationships with partners, investors, and collaborators.
The summit is tailored for senior BD&L professionals, alliance managers, investors, corporate development teams, licensors, and legal/IP strategists, aiming to maximize strategic partnerships and deal-making outcomes.
Registration, sponsorship, and presentation opportunities are now open. Join global leaders driving the future of pharma and biotech at pharma-partnering-summit.com/registration.html
Media Contact:
Olivia Grey
Email: olivia@pharma-partnering-summit.co.uk
Website: https://pharma-partnering-summit.com/eu-pps.html
